Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable - S&P Global Ratings’ Credit Research

Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable

Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable - S&P Global Ratings’ Credit Research
Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable
Published Apr 16, 2026
7 pages (3214 words) — Published Apr 16, 2026
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

S&P Global Ratings assigned its 'A+' long-term rating to the Indiana Finance Authority ?s $286.1 million series 2026A revenue bonds, issued for Parkview Health , Ind. (Parkview). At the same time, we affirmed our 'A+' long-term and underlying (SPUR) ratings on Parkview Health System Obligated Group , Ind.'s debt outstanding issued by the Indiana Finance Authority and on the series 2020A taxable bonds issued by Parkview. Finally, we affirmed our 'AA+/A-1' dual rating on the authority's series 2009B, 2009C, and 2009D bonds (assuming low correlation) issued for Parkview. The outlook, where applicable, is stable. The bonds outstanding are secured by a pledge of revenue of the credit group. The credit group consists of the parent, Parkview Health System, and Parkview

  
Brief Excerpt:

... diversified system of 15 hospitals across northeast Indiana and northwest Ohio. The flagship, Parkview Regional Medical Center, operates 549 beds in north Fort Wayne along with the Orthopedic Hospital at Parkview North (a 37-bed joint venture), and Parkview Hospital Randallia (187 licensed beds). Ratings List New Issue Ratings US$286.095 mil health sys rev bnds (Parkview Health System Obligated Group) ser 2026A due 10/01/2049 Long Term Rating A+/Stable Ratings Affirmed Healthcare Parkview Hlth Sys Oblig Grp, IN Health Care System Revenues A+/Stable The ratings appearing below the new issues represent an aggregation of debt issues (ASID) associated with related maturities. The maturities similarly reflect our opinion about the creditworthiness of the U.S. Public Finance obligor's legal pledge for payment of the financial obligation. Nevertheless, these maturities may have...

  
Report Type:

Research Update

Issuer
Sector
Global Issuers, Public Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable" Apr 16, 2026. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Parkview-Health-IN-Series-2026A-Revenue-Bonds-Assigned-A-Rating-Outlook-Stable-3547285>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: Parkview Health, IN Series 2026A Revenue Bonds Assigned 'A+' Rating; Outlook Stable Apr 16, 2026. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Parkview-Health-IN-Series-2026A-Revenue-Bonds-Assigned-A-Rating-Outlook-Stable-3547285>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.